141 related articles for article (PubMed ID: 35023549)
1. Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA).
White NJ; Watson JA; Simpson JA
Clin Infect Dis; 2022 Aug; 75(2):358. PubMed ID: 35023549
[No Abstract] [Full Text] [Related]
2. New leads for drug repurposing against malaria.
Pazhayam NM; Chhibber-Goel J; Sharma A
Drug Discov Today; 2019 Jan; 24(1):263-271. PubMed ID: 30099124
[TBL] [Abstract][Full Text] [Related]
3. Food and Drug Administration Approval of Artesunate for Severe Malaria: Enough to Achieve Best Practice?
Thomas CM; Stauffer WM; Alpern JD
Clin Infect Dis; 2023 Feb; 76(3):e864-e866. PubMed ID: 36056897
[TBL] [Abstract][Full Text] [Related]
4. Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs.
Kitchen LW; Vaughn DW; Skillman DR
Clin Infect Dis; 2006 Jul; 43(1):67-71. PubMed ID: 16758420
[TBL] [Abstract][Full Text] [Related]
5. Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
Kitabi E; Bensman TJ; Earp JC; Chilukuri DM; Smith H; Ball L; O'Shaughnessy E; Yasinskaya Y; Colangelo PM; Reynolds KS
Clin Infect Dis; 2021 Sep; 73(5):903-906. PubMed ID: 33605994
[TBL] [Abstract][Full Text] [Related]
6. A lesson learnt: the rise and fall of Lariam and Halfan.
Croft AM
J R Soc Med; 2007 Apr; 100(4):170-4. PubMed ID: 17404338
[No Abstract] [Full Text] [Related]
7. First artemisinin-based antimalarial combination approved for U.S. market.
Thompson CA
Am J Health Syst Pharm; 2009 May; 66(10):880. PubMed ID: 19420302
[No Abstract] [Full Text] [Related]
8. FDA launches priority vouchers for neglected-disease drugs.
Waltz E
Nat Biotechnol; 2008 Dec; 26(12):1315-6. PubMed ID: 19060849
[No Abstract] [Full Text] [Related]
9. Intravenous artesunate for the treatment of severe malaria.
Hess KM; Goad JA; Arguin PM
Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300
[TBL] [Abstract][Full Text] [Related]
10. Severe
Shah PJ; Koshy J; Everett N; Attia E
J Pharm Pract; 2020 Feb; 33(1):108-112. PubMed ID: 29898630
[TBL] [Abstract][Full Text] [Related]
11. Lariam's legacy.
Consum Rep; 2002 Mar; 67(3):60-1. PubMed ID: 11863012
[TBL] [Abstract][Full Text] [Related]
12. Malaria Surveillance - United States, 2016.
Mace KE; Arguin PM; Lucchi NW; Tan KR
MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
[TBL] [Abstract][Full Text] [Related]
13. Development of new drugs for chemoprophylaxis of malaria.
Milhous WK
Med Trop (Mars); 2001; 61(1):48-50. PubMed ID: 11584654
[TBL] [Abstract][Full Text] [Related]
14. Severe Malaria Treatment in the United States at the Precipice.
Krey RA; Travassos MA
Ann Intern Med; 2019 Sep; 171(5):362-363. PubMed ID: 31426092
[No Abstract] [Full Text] [Related]
15. Malaria Surveillance - United States, 2018.
Mace KE; Lucchi NW; Tan KR
MMWR Surveill Summ; 2022 Sep; 71(8):1-35. PubMed ID: 36048717
[TBL] [Abstract][Full Text] [Related]
16. Tafenoquine: First Global Approval.
Frampton JE
Drugs; 2018 Sep; 78(14):1517-1523. PubMed ID: 30229442
[TBL] [Abstract][Full Text] [Related]
17. Expanded Availability of Intravenous Artesunate for the Treatment of Severe Malaria in the United States.
Rosenthal PJ; Tan KR
Am J Trop Med Hyg; 2019 Jun; 100(6):1295-1296. PubMed ID: 30927931
[No Abstract] [Full Text] [Related]
18. Malaria medicine box expands.
Mullard A
Nat Rev Drug Discov; 2018 Oct; 17(10):693-695. PubMed ID: 30270351
[No Abstract] [Full Text] [Related]
19. Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under an Investigational New Drug Protocol.
Twomey PS; Smith BL; McDermott C; Novitt-Moreno A; McCarthy W; Kachur SP; Arguin PM
Ann Intern Med; 2015 Oct; 163(7):498-506. PubMed ID: 26301474
[TBL] [Abstract][Full Text] [Related]
20. Tafenoquine receives regulatory approval in USA for prophylaxis of malaria and radical cure of Plasmodium vivax.
Tan KR; Hwang J
J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30137454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
